NZACRes 2016 Conference
 
Programme - Friday 19 August
0730-0820 Registration Desk Open, Arrival Tea & Coffee and Exhibition Open
Regatta D
0820-0830 Welcome Back
Duncan Babbage, MC

0830-0900 Challenges in the NZ Clinical Trials Environment
Dr Richard Robson, Executive Director, Christchurch Clinical Studies Trust, Christchurch, NZ

0900-0930 ECG Assessment in Early Stage Clinical Trials Can Replace the Thorough QT Study
Dr Roger L. Whiting, President & CEO, Altos Therapeutics LLC, USA

0930-1000 Medical Devices and Clinical Trials
Mr Thodur Vasudevan, Consultant Vascular Surgeon, Waikato Hospital; Senior Lecturer, The University of Auckland, Hamilton, NZ

1000-1030 Panel Discussion - Conducting Clinical Trials in ANZ
Chair: Professor Richard S Stubbs
Panelists:
 - Richard Robson
 - John Moller
 - David Lloyd
 - Eileen Bisley
 - Nicole Signal

1030-1100 Morning Tea and Industry Exhibition
Morning Tea kindly provided by
 

Regatta D
1100-1130
Social Media and Clinical Trials
Melanie Gentgall, CEO, PRAXIS Australia Pty Ltd, Australia
Gallery 2
1100-1130
Challenges for CROs / Sponsors

Facilitators
Stuart Ryan, Medical and Clinical Manager, Roche NZ, Auckland, NZ
Isobel Smith, Senior Manager, Clinical Management, PPD, Rangiora, NZ

1130-1200
Novel Vaccines for the Treatment of Cancer
Associate Professor Ian Hermans, Deputy Director, Malaghan Institute of Medical Research, Wellington, NZ

1130-1200
Challenges for Sites

Facilitators: 
Sandy McGreevy, Charge Nurse Manager - Research, Middlemore Clinical Trials, Counties Manukau DHB, Auckland, NZ
Eileen Bisley, Managing Director, Clinical Trials NZ Ltd, Hamilton, NZ

1200-1230
Let’s Work Together for Public Good: PHARMAC's Place in the Research Ecosystem

Dr Jacqueline Evans, Research Manager, PHARMAC, Wellington, NZ

1200-1230
Fairness around Budgets

Facilitators
Jan Gaskin, Director, Site Management Delivery, Country Head, Quintiles, Auckland, NZ
Jo Sanders, Operations Manager, Christchurch Clinical Studies Trust, Christchurch, NZ


 
1230-1330 Lunch and Industry Exhibition
Lunch kindly provided by


Regatta D
1330-1400
Research Developments

Clinical Trials Modulating the Gut to Improve Type 2 Diabetes
Dr Rinki Murphy
Specialist Diabetes Physician, Auckland DHB, Counties Manukau DHB & Mercy Specialist Centre; Senior Lecturer in Medicine, The University of Auckland, Auckland, NZ
Gallery 2
Chair: Zoe Breeze, Roche
1330-1350
Free Paper Sessions

Chasing Micro-Organisms from a Simulated Operating Theatre to the Clinical Anaesthesia Environment
Derryn Gargiulo, Department of Anaesthesiology, The Faculty of Medical and Health Sciences, The University of Auckland, NZ

Adherence and Time-to-First Discontinuation in Donepezil New Users: A Three-Year Population-Based Study in Older People
Henry Ndukwe, School of Pharmacy, University of Otago, Dunedin, NZ

1400-1430
Venous Thromboembolism and Long Distance Travelling
Irene Braithwaite, Deputy Director
Medical Research Institute of New Zealand, Wellington, NZ

1400-1430
Use of Clinical Data and Tissue for Research Purposes without Explicit Patient Consent
Dr Angela Ballantyne, Senior Lecturer Bioethics, University of Otago, Wellington, NZ


1430-1500
Pharma Research - How Pharma Companies Scope for Clinical Trials
Stuart Ryan, Medical and Clinical Manager, Roche NZ, Auckland, NZ

1430-1500
The Ethics of Comparative Effectiveness Research - Making Large Trials Feasible
Nic Aagaard, Senior Advisor, Ethics Committees, Ministry of Health, Wellington, NZ

1500-1530
A Health Research Strategy for New Zealand
Professor Kathryn McPherson, Chief Executive, Health Research Council of New Zealand, Auckland, NZ

1500-1530
Therapeutic Products Regulations
Chris James, Acting Group Manager, Medsafe, Ministry of Health, Wellington, NZ
James Caldwell, Senior Policy Analyst, Transformation Team, Sector and Services Policy, Strategy and Policy, Ministry of Health, Wellington, NZ


1530-1545 Conference Close

1545-1700 Informal Networking
Please feel free to seek out other delegates who you wish to network with and meet in the Omni Bar in the foyer of the Pullman Hotel at the end of the conference.